Origin of SAS code? [Software]

posted by Helmut Homepage – Vienna, Austria, 2020-07-03 14:46 (148 d 22:23 ago) – Posting: # 21644
Views: 1,406

Hi Mahmoud,

» in the following SAS code

where does this code come from? It’s not the standard one recommended by the FDA here and there.

» model AUCT=sequence period treat/DDFM=kr;

I would suggest to use DDFM=SATTER (as the FDA recommends). The default of DDFM=KR uses the observed information matrix (SCORING=0) as does JMP. You may run into troubles if your study is re-evaluated in other software which uses the expected information matrix (e.g., Stata, R-package replicateBE). In SAS you can get the expected information matrix by setting SCORING=1.

» random treat/type=CSH subject=subject G;
» In the Random statement TYPE=CSH could possibly be replaced by TYPE=FA(1)

Acc. to the FDA’s guidance, Appendix E:

In the Random statement, TYPE=FA0(2) could possibly be replaced by TYPE=CSH.

So why compound symmetry in the first place?

» FA(1) is not the same as FA0(2)

Of course. FA(q) = factor analytic and FA0(q) = no diagonal factor analytic.
If this is a full replicate design, I would follow the FDA’s recommendation and use FA0(2).
However, in the stupid partial replicate designs (TRR|RTR|RRT or TRR|RTR) the optimizer may fail to converge since the model is over-specified (T not repeated). Then you’ve performed a study and don’t get a result cause SAS shows you the finger.* I suggest to specify FA0(1) instead. State that already in the SAP.

Dif-tor heh smusma 🖖
Helmut Schütz

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

 Admin contact
21,217 posts in 4,427 threads, 1,481 registered users;
online 21 (0 registered, 21 guests [including 15 identified bots]).
Forum time: Sunday 12:09 CET (Europe/Vienna)

Half the harm that is done in this world
Is due to people who want to feel important.    T. S. Eliot

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz